This episode features Thad Wolfram, President of EmVenio Research. As EmVenio joins the SCRS Global Impact Program (GIP), Thad shines light on EmVenio’s dedication to providing clinical trial access for underrepresented and underserved communities. The episode further touches on the importance of diversity, community, and how localized data can help expand a clinical trial's international footprint.